The rapid emergence of longevity, anti-aging, and peptide therapies has created tremendous patient enthusiasm, but also unprecedented scrutiny from the FDA and state medical boards. Regulatory shifts regarding Category 2 bulk drug substances and compounding restrictions on popular peptides require clinics to operate with sophisticated clinical governance. Longevity clinics must maintain thorough baseline evaluations, establish defensible treatment rationale, and source compounds exclusively from verified, legitimate pharmacies. Access Plus Health provides forward-thinking, board-certified medical directors who specialize in functional and longevity medicine. We establish evidence-informed clinical protocols, patient consent documentation, and biomarker tracking workflows that meet rigorous medical board scrutiny. Our clinical directorship enables anti-aging practices to offer cutting-edge regenerative therapies while maintaining complete compliance with evolving pharmaceutical regulations and medical practice standards.